S100B and Alzheimer disease: Studies reported increased levels of S100B in cerebrospinal fluid (CSF) in mild/moderate AD compared to severe AD and healthy controls (Peskind et al., 2001), or in AD if compared with healthy controls (Petzold et al., 2003; Bellaver et al., 2021).